Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentoxifylline for Proteinuria in Lupus Nephritis
NCT03859570Phase 4Withdrawn
- Sponsor
- MetroHealth Medical Center
- Start
- Sep 2020
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of pentoxifylline in lupus nephritis (LN), sponsored by MetroHealth Medical Center. Planned start Sep 2020; status: withdrawn.
02
Drugs
pentoxifylline
03
Conditions
lupus nephritis (LN)
Beyond the preview
Go deeper on NCT03859570.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03859570.